Condition: Heart Failure and Reduced Ejection Fraction · Functional Mitral Regurgitation · Sponsor: Minneapolis Heart Institute Foundation
This is a multi-center, prospective, observational study designed to evaluate the impact of LV myocardial fibrosis extent assessed by CMR on LV reverse remodeling and clinical outcomes post TEER. The target sample will be up to 125 patients enrolled to achieve 100 evaluable at 6 months of follow-up. Enrollment will occur at up to eight centers.
This description comes directly from the study's public registry record.
João Cavalcante, MD · 612-863-3900 · joao.cavalcante@allina.com
Sarah Schwager, RN · 612-863-6257 · sarah.schwager@allina.com
Always discuss trial participation with your own doctor first.
| Minneapolis Heart Institute Foundation | Minneapolis, Minnesota, United States | Recruiting |
| Sanger Heart and Vascular Institute | Charlotte, North Carolina, United States | Enrolling By Invitation |
| The Christ Hospital Health Network | Cincinnati, Ohio, United States | Enrolling By Invitation |
| Cleveland Clinic | Cleveland, Ohio, United States | Enrolling By Invitation |
| Inova Fairfax Medical Campus | Falls Church, Virginia, United States | Enrolling By Invitation |
| IRCCS Ospedale San Raffaele | Milan, Italy | Enrolling By Invitation |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07131631